1. Home
  2. ROG vs AUPH Comparison

ROG vs AUPH Comparison

Compare ROG & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rogers Corporation

ROG

Rogers Corporation

HOLD

Current Price

$99.74

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$14.76

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROG
AUPH
Founded
1832
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
ROG
AUPH
Price
$99.74
$14.76
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
$85.00
$17.25
AVG Volume (30 Days)
123.3K
994.1K
Earning Date
02-18-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.55
Revenue
$801,500,000.00
$265,808,000.00
Revenue This Year
N/A
$21.76
Revenue Next Year
$7.31
$16.45
P/E Ratio
N/A
$27.00
Revenue Growth
N/A
20.62
52 Week Low
$51.43
$6.55
52 Week High
$102.29
$16.54

Technical Indicators

Market Signals
Indicator
ROG
AUPH
Relative Strength Index (RSI) 65.96 39.81
Support Level $91.87 $14.74
Resistance Level $102.29 $15.28
Average True Range (ATR) 2.72 0.50
MACD 0.30 -0.13
Stochastic Oscillator 77.79 21.87

Price Performance

Historical Comparison
ROG
AUPH

About ROG Rogers Corporation

Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: